留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Turning the corner from observation to intervention in human genetics

David L. Nelson

David L. Nelson. Turning the corner from observation to intervention in human genetics[J]. Journal of Genetics and Genomics, 2018, 45(2): 57-59. doi: 10.1016/j.jgg.2018.01.004
Citation: David L. Nelson. Turning the corner from observation to intervention in human genetics[J]. Journal of Genetics and Genomics, 2018, 45(2): 57-59. doi: 10.1016/j.jgg.2018.01.004

doi: 10.1016/j.jgg.2018.01.004

Turning the corner from observation to intervention in human genetics

  • [1] Batra, R., Nelles, D.A., Pirie, E. et al. Elimination of toxic microsatellite repeat expansion RNA by RNA-targeting Cas9 Cell, 170 (2017)
    [2] Boycott, K.M., Rath, A., Chong, J.X. et al. International cooperation to enable the diagnosis of all rare genetic diseases Am. J. Hum. Genet., 100 (2017),pp. 695-705
    [3] Church, G. Compelling reasons for repairing human germlines N. Engl. J. Med., 377 (2017),pp. 1909-1911
    [4] Cohen, J.C., Boerwinkle, E., Mosley, T.H. et al. N. Engl. J. Med., 354 (2006),pp. 1264-1272
    [5] Couzin, J., Kaiser, J. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow Science, 307 (2005),p. 1028
    [6] Eichler, F., Duncan, C., Musolino, P.L. et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy N. Engl. J. Med., 377 (2017),pp. 1630-1638
    [7] Ertl, H.C.J., High, K.A. Impact of AAV capsid-specific T-cell responses on design and outcome of clinical gene transfer trials with recombinant adeno-associated viral vectors: an evolving controversy Hum. Gene Ther., 28 (2017),pp. 328-337
    [8] Finkel, R.S., Mercuri, E., Darras, B.T. et al. N. Engl. J. Med., 377 (2017),pp. 1723-1732
    [9] Freed, D., Pevsner, J. The contribution of mosaic variants to autism spectrum disorder PLoS Genet., 12 (2016)
    [10] George, L.A., Sullivan, S.K., Giermasz, A. et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant N. Engl. J. Med., 377 (2017),pp. 2215-2227
    [11] Gillentine, M.A., Yin, J., Bajic, A. et al. Am. J. Hum. Genet., 101 (2017),pp. 874-887
    [12] Grasemann, H. CFTR modulator therapy for cystic fibrosis N. Engl. J. Med., 377 (2017),pp. 2085-2088
    [13] Hall, S.S. Genetics: a gene of rare effect Nature, 496 (2013),pp. 152-155
    [14] Hirsch, T., Rothoeft, T., Teig, N. et al. Regeneration of the entire human epidermis using transgenic stem cells Nature, 551 (2017),pp. 327-332
    [15] Kaiser, J. A second chance Science, 358 (2017),pp. 582-585
    [16] Kaiser, J. A human has been injected with gene-editing tools to cure his disabling disease. Here's what you need to know Science (2017)
    [17] Khan, S.S., Shah, S.J., Klyachko, E. et al. Sci. Adv., 3 (2017)
    [18] Ledford, H. FDA advisers back gene therapy for rare form of blindness Nature, 550 (2017),p. 314
    [19] Lim, E.T., Uddin, M., De Rubeis, S. et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder Nat. Neurosci., 20 (2017),pp. 1217-1224
    [20] Liu, X.S., Wu, H., Ji, X. et al. Editing DNA methylation in the mammalian genome Cell, 167 (2016)
    [21] Ma, H., Marti-Gutierrez, N., Park, S.-W. et al. Correction of a pathogenic gene mutation in human embryos Nature, 548 (2017),pp. 413-419
    [22] Mendell, J.R., Al-Zaidy, S., Shell, R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy N. Engl. J. Med., 377 (2017),pp. 1713-1722
    [23] Ormond, K.E., Mortlock, D.P., Scholes, D.T. et al. Human germline genome editing Am. J. Hum. Genet., 101 (2017),pp. 167-176
    [24] Pinto, B.S., Saxena, T., Oliveira, R. et al. Impeding transcription of expanded microsatellite repeats by deactivated Cas9 Mol. Cell, 68 (2017)
    [25] Powell, S.K., Gregory, J., Akbarian, S. et al. Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease Mol. Cell. Neurosci., 82 (2017),pp. 157-166
    [26] Rangarajan, S., Walsh, L., Lester, W. et al. AAV5-factor VIII gene transfer in severe hemophilia A N. Engl. J. Med., 377 (2017),pp. 2519-2530
    [27] Rao, A.N., Cooper, T.A. A therapeutic double whammy: transcriptional or post-transcriptional suppression of microsatellite repeat toxicity by Cas9 Mol. Cell, 68 (2017),pp. 473-475
    [28] Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E. et al. Gene therapy in a patient with sickle cell disease N. Engl. J. Med., 376 (2017),pp. 848-855
    [29] Russell, S., Bennett, J., Wellman, J.A. et al. Lancet, 390 (2017),pp. 849-860
    [30] Verkerk, A.J., Pieretti, M., Sutcliffe, J.S. et al. Cell, 65 (1991),pp. 905-914
    [31] Zhao, Z., Tuakli-Wosornu, Y., Lagace, T.A. et al. Am. J. Hum. Genet., 79 (2006),pp. 514-523
  • 加载中
计量
  • 文章访问数:  67
  • HTML全文浏览量:  19
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-12-02
  • 录用日期:  2018-01-14
  • 修回日期:  2018-01-04
  • 网络出版日期:  2018-02-21
  • 刊出日期:  2018-02-20

目录

    /

    返回文章
    返回